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Multiplex PCR amplification followed by either agarose gel electrophoresis (PCR-AGE) or microchip
electrophoresis (PCR-ME) was used to test a total of 120 fungal strains. The internal transcribed spacer 1
(ITS1) and ITS2 regions and the 5.8S ribosomal DNA (rDNA) region of the fungi were amplified by using
universal primers ITS1 and ITS4. The ITS2 region was simultaneously amplified by using universal primers
ITS3 and ITS4. Since Trichosporon asahi and T. asteroides showed similar lengths for two amplicons, 29
different gel patterns were demonstrated for 30 yeast species tested on the basis of differences in the lengths
of one or two amplicons. Of 75 yeast isolates from clinical materials, 5 isolates (6.8%) which were incompletely
identified or not identified by the phenotypic method were identified with our PCR-based method (2 isolates
as Candida guilliermondii, 2 as C. krusei, and 1 as C. zeylanoides). No differences in discriminating power or
sensitivity were observed between the PCR-AGE method and the PCR-ME method. These methods, prospec-
tively applied to 24 yeast-positive blood culture bottles (16 patients), resulted in the correct detection of 24
yeast strains. In conclusion, multiplex PCR followed by electrophoresis seems to be a promising tool for the
rapid identification of common and uncommon yeast strains from culture colonies and from yeast-positive
blood culture bottles (5.5 h for the PCR-AGE method and 3 h for the PCR-ME method).
The virulence of Candida isolates differs according to the
species, with Candida albicans being most virulent, followed by
C. tropicalis (23); thus, the prompt and accurate detection and
identification of yeast species are very important. Detection
and identification have been made even more important be-
cause of the emergence of candidemia caused by innately flu-
conazole-resistant non-C. albicans Candida species (12). Var-
ious commercial systems that can identify these pathogens
within 4 to 72 h have been developed (2). Although correct
identification of clinically relevant yeast strains can be achieved
with these systems, incomplete or incorrect identification may
occur when certain new and emerging yeast strains are tested
(2). Moreover, culture-based phenotypic identification of Can-
dida species from clinical materials requires at least 1 day to
obtain a pure culture.
PCR-based methods for the rapid detection and identifica-
tion of Candida species have also been described. These in-
clude restriction fragment length polymorphism analysis (3),
PCR-restriction fragment length polymorphism analysis (7,
11), PCR with species-specific probes (14, 15), and random
amplification of polymorphic DNA analysis (16). These meth-
ods have already shown great promise in the field of species
identification and strain delineation. However, none of these
methods has yet been used in the clinical laboratory.
PCR with fungus-specific primers, targeting the conserved
sequences of 5.8S and 28S ribosomal DNAs (rDNAs) as well as
those of 18S and 28S rDNAs, results in the respective ampli-
fication of the species-specific internal transcribed spacer (ITS)
2 (ITS2) region and of the ITS1 and ITS2 regions, which vary
in amplicon length and sequence according to species (4, 6).
Recently, Turenne et al. reported that differences in the sizes
of the ITS2 regions of fungi were useful for the rapid identi-
fication of clinically important fungi (20). However, they found
only a three-nucleotide band difference when comparing the
lengths of C. albicans and C. krusei ITS2 amplicons. We used
the variability in the lengths of both ITS1 and ITS2 regions to
achieve the specific identification of fungal strains, and we
determined the lengths of PCR fragments by using both aga-
rose gel electrophoresis (AGE) and microchip electrophoresis
(ME).
MATERIALS AND METHODS
Organisms. The 45 strains used in this study as control strains are listed in
Table 1. These included 40 strains obtained from the Institute of Fermentation
(IFO), Osaka, Japan; 4 strains obtained from the Japan Collection of Microor-
ganisms (JCM), Institute of Physical and Chemical Research, Wako, Japan; and
1 strain (given the prefix K) which has been identified and maintained in our
laboratory.
Seventy-five clinical isolates were obtained from patients at the Kanazawa
University Hospital. Presumptive identification of these isolates was made by
means of colony color on CHROMagar Candida medium, and the isolates were
definitively identified with an API 20C kit (bioMerieux-Vitek, Hazelwood, Mo.).
When necessary, their abilities to produce germ tubes and chlamydospores and
to grow at 42°C were tested. These isolates comprised C. albicans (n  23),
C. tropicalis (n 12), C. parapsilosis (n 6), C. guilliermondii (n 9), C. glabrata
(n  8), C. krusei (n  6), Cryptococcus neoformans (n  6), and incompletely
identified or unidentified strains (n  5).
DNA extraction. The Zymolyase-based method used to extract DNA has been
described previously (3). In brief, yeast isolates were grown on CHROMagar
Candida medium for 24 to 48 h at 35°C. Single colonies were inoculated into 1
ml of Tris-EDTA (TE) buffer at a McFarland standard of 0.5. Aspergillus strains
were grown on Sabouraud dextrose agar for 3 days, and the conidia were inoc-
ulated into TE buffer. After centrifugation (5,000  g, 3 min) in an Eppendorf
microcentrifuge, the sediments were resuspended in 0.1 ml of 1 M sorbitol–1 M
EDTA (pH 7.5) containing 5 l of -mercaptoethanol and 1 to 2 mg of Zymol-
yase; the mixture was incubated for 15 min at 37°C. For filamentous fungi, 1 to
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2 mg of lysing enzymes (Sigma Chemical Co., St. Louis, Mo.) was added to the
tube, and the mixture was incubated for a further 15 min at 37°C. Finally, 5 l of
proteinase K solution (20 mg/ml) was added to the tube, and the mixture was
incubated at 55°C for 10 min and in a boiling water bath for 5 min.
Blood cultures. A total of 4 to 8 ml of blood drawn from each patient was
inoculated into aerobic and anaerobic blood culture bottles (Organon Teknika
Corp., Durham, N.C.). All bottles were incubated in a BACTEC 9240 automated
system. When microbial growth was detected by the system, microscopic exam-
inations using Gram staining and subcultures were performed. Yeast-positive
bottles were immediately processed for DNA extraction, and a prospective iden-
tification of the blood isolate was made on the basis of results obtained with the
commercial system and PCR analysis. Ten randomely selected samples from
patients with bacteremia were also tested as negative controls.
Processing of blood samples for PCR. About 0.2 ml of blood culture fluid from
each bottle was inoculated into a tube containing 1 ml of 0.17% sodium dodecyl
sulfate, and this mixture was diluted with 8 to 10 ml of sterile distilled water.
After centrifugation (3,000g, 10 min), the pellets were placed in 1 ml of TE
buffer and processed with the same method as that described above. Purified
DNA was obtained with a MagExtract DNA extraction kit (Toyobo Co. Ltd.,
Osaka, Japan); about 1 h was required to disrupt and isolate DNA from positive
blood culture bottles.
PCR procedure. Primers ITS1 (5-TCCGTAGGTGAACCTGCG-3), ITS3
(5-GCATCGATGAAGAACGCAGC-3), and ITS4 (5-TCCTCCGCTTATTG
ATATGC-3), targeting the conserved regions of 18S, 5.8S, and 28S rDNAs (22),
respectively, were used for amplification. The ITS1-ITS4 primer pair was used to
amplify the intervening 5.8S rDNA and the adjacent ITS1 and ITS2 regions, and
the ITS3-ITS4 primer pair was used to amplify a large portion of the 5.8S rDNA
and the adjacent ITS2 region (Fig. 1). PCR amplification was performed with a
volume of 50 l. Two microliters of each sample was added to the PCR master
mixture, which consisted of 5 l of 10 PCR buffer, 4 l of a deoxynucleoside
triphosphate mixture (0.1 mM each dNTP), 0.8 l of each primer (40 pmol of
each primer), and 0.4 l (2.0 U) of ExTaq DNA polymerase (Takara Biomedi-
cals, Osaka, Japan), with the remaining volume consisting of distilled water.
Amplification consisted of an initial denaturation at 94°C for 4 min; 30 cycles of
denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C
for 1 min; and a final extension at 72°C for 4 min; a GeneAmp PCR system 9600
thermal cycler (Perkin-Elmer Corp., Emeryville, Calif.) was used. Negative con-
trol reactions without any template DNA were carried out simultaneously.
Electrophoresis. Gel electrophoresis with 1.5% agarose gels was conducted
with 1 TBE buffer (0.1 M Tris, 0.09 M boric acid, 1 mM EDTA) at 4.8 V/cm
for 2 h. A 100-bp DNA ladder (Promega Corp., Madison, Wis.) was run con-
currently with amplicons for sizing of the bands. Gels were stained with ethidium
bromide-TBE solution for 20 min and then photographed. The computer pro-
gram Diversity Database (PDI Inc., New York, N.Y.) was used to calculate
molecular sizes. Fragment sizes of control strains were measured three times for
each strain on different gels. In addition to AGE, PCR products were analyzed
with an ME instrument (model SV1100; Hitachi Electronics Engineering Co.
Ltd., Tokyo, Japan). The microchip had three sample wells, and wells were
TABLE 1. Summary of sizes of PCR-amplified fragments by species
Organism Strain(s)
Fragment size, in bp, found by PCR with
the following primer pairsa:
ITS1-ITS4 ITS3-ITS4
Candida albicans IFO 1398, IFO 1974, IFO 1061 529–535 (532) 335–342 (339)
Candida catenulata IFO 0745 391–393 (392) 262–266 (264)
Candida famata IFO 0664, IFO 856 632–634 (633) 369–370 (370)
Candida glabrata IFO 0005, IFO 0622 869–879 (874) 412–418 (415)
Candida guilliermondii IFO 10279, IFO 1972, IFO 0566 598–607 (603) 375–380 (378)
Candida holmii IFO 1629 717–717 (717) 431–432 (432)
Candida inconspicua IFO 0621 447–449 (448) 298–299 (299)
Candida intermedia IFO 0761 384–388 (386) 250–256 (253)
Candida kefyr IFO 0586, IFO 10287, IFO 1065 720–723 (722) 422–427 (425)
Candida krusei IFO 0584 496–503 (500) 332–338 (335)
Candida lambica IFO 10289 432–434 (434) 301–304 (303)
Candida lipolytica IFO 1549, IFO 1548 358–359 (359) 233–239 (236)
Candida lusitaniae IFO 10059, IFO 10058 373–378 (375) 245–254 (250)
Candida norvegensis IFO 1020 480–483 (482) 314–315 (315)
Candida parapsilosis IFO 1396 511–521 (516) 308–314 (311)
Candida rugosa IFO 1364 416–419 (418) 268–269 (269)
Candida saitoana IFO 0768 611–614 (613) 365–368 (367)
Candida tropicalis IFO 1400, IFO 10241 517–524 (521) 326–331 (329)
Candida utilis IFO 10707 553–555 (554) 354–357 (356)
Candida zoylanoides IFO 10326 620–622 (621) 367–369 (368)
Cryptococcus neoformans K615 547–555 (550) 370–375 (372)
Cryptococcus humicolus IFO 10251 520–525 (522) 335–339 (337)
Dipodascus capitatus IFO 1197 454–457 (456) 296–297 (297)
Pichia anomala IFO 10213 614–615 (615) 373–376 (375)
Pichia chambardii IFO 1274 629–630 (630) 380–382 (381)
Saccharomyces cerevisiae IFO 0565 835–839 (837) 414–417 (416)
Stephanoascus ciferrii IFO 1854, JCM 9551 571–572 (572) 354–356 (355)
Trichosporon asahii JCM 2466 535–537 (536) 352–356 (354)
Trichosporon asteroides JCM 10016 537–540 (539) 354–357 (356)
Trichosporon cutaneum JCM 1462 521–523 (522) 348–349 (349)
Aspergillus flavus IFO 5839 581–585 (583) 340–349 (345)
Aspergillus fumigatus IFO 7839 580–588 (584) 337–347 (342)
Aspergillus niger IFO 4414 586–590 (588) 342–350 (346)
a Range (mean) from three separate experiments.
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connected with a cross- channel 0.1 mm wide, 0.03 mm deep, and 45 mm long.
After the channel was filled with 0.6% hydroxypropyl methylcellulose containing
ethidium bromide, a mixture of 9 l of PCR products and 1 l of loading buffer
containing the internal standards (100 and 800 bp) was loaded into one of the
sample wells of the microchip; the program was run at 300 V for 1 min (injection
time) and at 750 V for 3 min (separation time). Accurate fragment size analysis
based on the electrophoretic mobility of the sample relative to the internal
standards was achieved by using DNA size analysis software.
RESULTS
To determine the sensitivity of the PCR followed by elec-
trophoresis, 0.5-ml aliquots of TE buffer were seeded with 0,
101, 102, 103, 104, or 105 C. albicans blastoconidia. The sensi-
tivity of PCR-AGE and PCR-ME was 103 cells per 0.5 ml of
buffer, or 20 cells per 2 l of sample.
For the isolation of yeast DNA from culture colonies, 40 min
was required; in comparison, 1 h is required for DNA isolation
from yeast-positive blood culture bottles. For the PCR-AGE
method, 2 h was required for PCR amplification, 2 h was
required for AGE (4 min for ME), and 30 min was required for
staining and fragment analysis. Therefore, the times from
yeast-positive blood culture bottles to genus or species identi-
fication by our PCR-based method were about 5.5 h for the
PCR-AGE method and about 3 h for the PCR-ME method.
Amplification of all fungi tested with ITS1 and ITS4 primers
yielded fragments 350 to 880 bp long, while ITS3 and ITS4
primers yielded fragments 233 to 432 bp long. The sizes of the
PCR products amplified with the former were nearly equal for
some species: C. parapsilosis and C. tropicalis, about 520 bp;
C. utilis and C. neoformans, about 554 bp; and C. saitoana and
Pichia anomala, about 614 bp. However, these organisms
showed species-specific differences in the sizes of the PCR
products amplified with ITS3 and ITS4 primers. In contrast,
the sizes of the PCR products amplified with ITS3 and ITS4
primers were identical for C. albicans, C. krusei, and C. humi-
colus and for C. famata, C. neoformans, and P. anomala. The
PCR products amplified with ITS3 and ITS4 primers were
about 356 bp long for C. utilis and Stephanoascus ciferrii. How-
ever, these organisms showed species-specific differences in the
sizes of the PCR products amplified with ITS1 and ITS4 prim-
ers. On the other hand, the lengths of two amplicons of Tri-
chosporon asahi and T. asteroides were almost equal. Three
Aspergillus species tested also demonstrated fragments of equal
or nearly equal lengths. Therefore, 30 genus- or species-spe-
cific patterns were recognized among the 33 fungal species on
the basis of differences in the lengths of one or two fragments
of amplicons (Table 1). No intraspecies variability was de-
tected.
Seventy-five isolates identified with routine phenotypic iden-
tification methods were correctly identified by the species-
specific patterns shown in Table 1. The results of electrophore-
sis of PCR products from eight Candida species are shown in
Fig. 2. ME analysis of 120 fungal strains showed that the
lengths of two amplicon were in agreement with the results
obtained with AGE analysis. The results obtained with the ME
method for three Candida species are shown in Fig. 3. The
standard deviations (SDs) of calculated molecular sizes ranged
from 1.20 to 3.36 with the AGE method and from 1.97 to 4.61
with the ME method (Table 2). Fragments having molecular
sizes with more than 2 SDs were considered different, a value
of about7 bp in the fragment size range of 300 to 500 bp. The
documented resolution of the ME instrument provided by the
manufacturer was specified as 10 bp. We concluded that the
AGE and ME methods could delineate strains which showed
differences of 10 bp or more in the mean lengths of either one
or two PCR products.
Five strains could not be identified with the API 20C kit, and
the code numbers of these strains were 6000004 (T. capitatum,
C. krusei, and C. lipolytica) for K10320, 6556377 (C. famata and
C. guilliermondii) for K7058, 6000104 (C. lipolytica and C. kru-
sei) for K447, 6116333 (no code) for K10585, and 6402224 (no
code) for K5701. The PCR-based method identified strains
K10320 and K447 as C. krusei, strains K7058 and K10585 as
C. guilliermondii, and strain K5701 as C. zeylanoides.
Twenty-four blood culture specimens obtained from 16 pa-
tients were positive for yeasts, as identified by primary Gram
stain. These blood isolates were identified as C. albicans (12
patients, 14 specimens), C. parapsilosis (1 patient, 1 specimen),
C. guilliermondii (1 patient, 4 specimens), C. glabrata (1 pa-
tient, 2 specimens), and C. neoformans (1 patient, 3 specimens)
with the conventional phenotypic identification method. The
results of this identification method were in agreement with
the results of the PCR-based identification method.
FIG. 1. Schematic representation of the fungal ribosomal genes containing the primer target areas used in this study.
FIG. 2. Gels showing amplification by PCR and length variations in
the ITS regions of medically important Candida isolates. Lane 1, C. al-
bicans; lane 2, C. dubliniensis; lane 3, C. tropicalis; lane 4, C. parapsi-
losis; lane 5, C. guilliermondii; lane 6, C. krusei; lane 7, C. glabrata; lane
8, C. lusitaniae; lanes M, 100-bp DNA ladder.
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The prompt and accurate identification of yeasts is becoming
increasingly important because new antifungal agents with dif-
ferent activities against various species are being developed
and because Candida species differ in their virulence charac-
teristics (5, 23). Although yeast identification kits such as the
RapID yeast system, API 20C kit, and ID 32C allow for simple
identification of yeast isolates, the ability to correctly identify
isolates at the species level differs significantly among the com-
mercial systems (21). For the API 20C kit, 5 to 10% incomplete
identification (i.e., supplemental tests were required for cor-
rect identification) has been reported for C. albicans, C. tropi-
calis, and C. glabrata strains (21). In our study, five Candida
strains incompletely identified or not identified with the API
20C kit were correctly identified with the PCR-based method
described here. Thanos et al. (19) have reported that three
Candida isolates incompletely identified with the ID 32C sys-
tem were correctly identified by PCR fingerprints (one each of
C. albicans, C. guilliermondii, and C. parapsilosis).
Various molecular approaches have been used for the de-
tection of fungi from clinical samples. Targets for the detection
of fungi at the genus or species level have included 18S rDNA
(9), mitochondrial DNA (4), intergenic spacer regions (13),
and ITS regions (7). The sizes of the 18S, 5.8S, and 26S rRNA
genes are essentially identical in all species, while the lengths
of the ITS regions depend on the species. The ITS region is
located between the 18S and 26S rRNA genes and is subdi-
vided into the ITS1 region, between the 18S and 5.8S rRNA
genes, and the ITS2 region, between the 5.8S and 26S rRNA
genes. Interspecies differences in fragment sizes or sequences
of the ITS1-5.8S rDNA-ITS2 regions (6, 7), ITS1 region (10),
and ITS2 region (8, 20) have been used to detect and identify
fungi. We utilized the differences in the lengths of both ITS1
and ITS2 regions to achieve specific identification of patho-
genic fungi from culture colonies.
In this study, most yeast strains were correctly identified at
the species level by means of gel electrophoresis, but C. albi-
cans and C. dubliniensis could not be differentiated because of
their nearly identical amplicon sizes (data not shown). C. dub-
liniensis is a recently reported species of chlamydospore- and
germ tube-positive yeast which has been isolated from the oral
cavities of human immunodeficiency virus-infected individuals.
Despite the many phenotypic similarities between C. dublini-
ensis and C. albicans, pronounced genetic differences between
the two species have been determined by DNA fingerprinting,
karyotype analysis, and DNA sequence analysis of rDNA (18).
However, no significant differences in fragment sizes were ob-
served with our PCR-based method. Therefore, we routinely
plate yeast isolates on CHROMagar Candida medium, and
colonies which have turned dark green after 48 h of incubation
are tested for their ability to grow at 42°C on Sabouraud agar
medium. Isolates which fail to grow or which grow poorly at
42°C are tentatively identified as C. dubliniensis. On the other
hand, five incompletely identified or unidentified strains were
identified as C. guilliermondii (two strains), C. krusei (two
strains), and C. zeylanoides (one strain) based on the charac-
teristic lengths of two amplicons. The multiplex PCR-based
method described here and used by us may thus be effective for
the preliminary identification of clinically uncommon or
emerging yeast isolates.
Sequences of the ITS1 and ITS2 regions of Trichosporon
species have been reported by Sugita et al. (17). They found
that the ITS1 and ITS2 regions of T. asahi and T. asteroides are
about 298 bp long and that those of T. cutaneum and T. mu-
coides are about 285 or 286 bp long. In addition, the lengths of
the PCR products, including the complete ITS1-5.8S rDNA-
ITS2 regions and portions of the 18S (30 bp) and 28S (59 bp)
rRNA genes, were identified as 595 bp for Aspergillus flavus,
596 to 598 bp for A. fumigatus, 599 bp for A. niger, and 609
to 613 bp for A. terreus (6). These previously reported results,
which are similar to ours, indicate that differences in the lengths
of the ITS regions of Trichosporon spp. and Aspergillus spp. are
of little value for species identification.
As for rapid sizing of PCR products, Turenne et al. (20) used
a capillary electrophoresis system which needs less than 30 min
for analysis. Recently, electrophoretic analysis with a micro-
chip was developed (1). To determine the lengths of PCR
products more rapidly, we used an ME instrument. This in-
strument can detect PCR products within 4 min, whereas AGE
used in our study needed 2 h to determine the lengths of
amplicons. The former has enabled us to generate a profile of
the expected amplicon sizes for a broad range of yeasts, thus
allowing for their rapid identification. The advantages of using
such an instrument include speed and the elimination of slab
gels and staining steps as well as of species-specific probes or
DNA sequencing. Furthermore, minimal manual labor is re-
quired, thus making the fragment detection system accurate
and cost-effective. To the best of our knowledge, this is the first
study in which the ME analysis system was used in a clinical
microbiology laboratory for determining the lengths of PCR
products.
Because our PCR-based method with universal primers am-
plified all kinds of genomic DNA from fungal strains, its use
may be limited to culture colonies on agar plates. The major
limitation of our PCR-based method for the direct detection of
fungi from clinical samples is mixed flora. Mixed candidemia,
which was not observed during our study, has a reported fre-




Base pair determination (mean  SD)
of PCR fragments by:
AGE ME
C. albicans (36) 337  2.77 338  3.04
533  2.73 531  3.09
C. tropicalis (14) 327  264 328  2.79
521  2.33 520  3.09
C. parapsilosis (8) 309  1.20 309  2.79
519  3.31 518  3.21
C. guilliermondii (13) 376  1.85 377  2.89
602  2.64 601  3.02
C. krusei (7) 333  2.96 335  3.02
499  3.01 499  3.12
C. glabrata (11) 414  2.54 416  1.97
874  3.36 873  4.61
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quency of 3.3% (14 of 427 patients) (12). In our preliminary
study, electrophoresis of PCR products obtained from a mix-
ture of C. albicans and C. glabrata cultures showed four frag-
ments, indicating mixed flora. Therefore, when four or more
fragments are detected with the PCR-AGE or PCR-ME
method, the presence of mixed flora should be taken into
consideration and the identification of fungi may be difficult.
In summary, we have developed a method for the com-
prehensive identification of clinically relevant fungal iso-
lates which is sensitive, rapid, and specific for all yeast organ-
isms tested. Using this PCR-ME analysis system, we are now
processing yeast-positive blood culture bottles as well as iden-
tifying problematic isolates of yeasts in routine laboratory
work.
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